Näreoja Tuomas, Rosenholm Jessica M, Lamminmäki Urpo, Hänninen Pekka E
Laboratory of Biophysics, Institute of Biomedicine and Medicity research laboratories, University of Turku, Tykistökatu 6A, 20520, Turku, Finland.
Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, F46, Karolinska Universitetssjukhuset, Huddinge, 141 86, Stockholm, Sweden.
Anal Bioanal Chem. 2017 May;409(13):3407-3416. doi: 10.1007/s00216-017-0284-z. Epub 2017 Mar 16.
Thyrotropin or thyroid-stimulating hormone (TSH) is used as a marker for thyroid function. More precise and more sensitive immunoassays are needed to facilitate continuous monitoring of thyroid dysfunctions and to assess the efficacy of the selected therapy and dosage of medication. Moreover, most thyroid diseases are autoimmune diseases making TSH assays very prone to immunoassay interferences due to autoantibodies in the sample matrix. We have developed a super-sensitive TSH immunoassay utilizing nanoparticle labels with a detection limit of 60 nU L in preprocessed serum samples by reducing nonspecific binding. The developed preprocessing step by affinity purification removed interfering compounds and improved the recovery of spiked TSH from serum. The sensitivity enhancement was achieved by stabilization of the protein corona of the nanoparticle bioconjugates and a spot-coated configuration of the active solid-phase that reduced sedimentation of the nanoparticle bioconjugates and their contact time with antibody-coated solid phase, thus making use of the higher association rate of specific binding due to high avidity nanoparticle bioconjugates. Graphical Abstract We were able to decrease the lowest limit of detection and increase sensitivity of TSH immunoassay using Eu(III)-nanoparticles. The improvement was achieved by decreasing binding time of nanoparticle bioconjugates by small capture area and fast circular rotation. Also, we applied a step to stabilize protein corona of the nanoparticles and a serum-preprocessing step with a structurally related antibody.
促甲状腺激素或甲状腺刺激激素(TSH)用作甲状腺功能的标志物。需要更精确、更灵敏的免疫测定法,以促进对甲状腺功能障碍的持续监测,并评估所选治疗方法和药物剂量的疗效。此外,大多数甲状腺疾病是自身免疫性疾病,由于样品基质中的自身抗体,TSH测定极易受到免疫测定干扰。我们开发了一种超灵敏的TSH免疫测定法,通过减少非特异性结合,在预处理血清样品中的检测限为60 nU/L。通过亲和纯化开发的预处理步骤去除了干扰化合物,并提高了血清中加标TSH的回收率。通过稳定纳米颗粒生物共轭物的蛋白质冠层和活性固相的点涂配置提高了灵敏度,该配置减少了纳米颗粒生物共轭物的沉降及其与抗体包被固相的接触时间,从而利用了高亲和力纳米颗粒生物共轭物导致的更高特异性结合缔合速率。图形摘要我们能够使用铕(III)纳米颗粒降低TSH免疫测定的最低检测限并提高灵敏度。通过小捕获面积和快速圆周旋转减少纳米颗粒生物共轭物的结合时间实现了这一改进。此外,我们应用了一个步骤来稳定纳米颗粒的蛋白质冠层,并使用结构相关抗体进行血清预处理步骤。